

Cover Story
Capitol HillFree
By Matthew Bin Han Ong
After taking eight months to respond to a House committee’s questions about policies on handling of sexual misconduct cases, a letter from NIH has provided answers that critics describe as vague and inadequate.
In Brief


Clinical Roundup


Drugs & Targets
Trending Stories
- Trump backs off the 100% pharma tariffs ultimatum
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- Latinx oncology leaders talk about the impact of federal policy on cancer outcomes in Latinx communities
- ASCO and Google Cloud set forth a vision for using AI to modernize health care and advance oncology
- The insinuation that AstroTurf causes GBM has no basis in science
The Philadelphia Inquirer series does disservice to brain tumor community - Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research